Baum Hedlund Aristei & Goldman changed its name to Wisner Baum in January 2023.

SSRI Documents

Wisner Baum’s SSRI Documents

PDF References

Testimony before the Psychopharmacologic Drugs Advisory Committee (PDAC)

Results of FDA’s Ongoing Meta-analysis of Suicidality Data from Adult Antidepressant Trials

December 13, 2006

Wisner Baum (formerly Baum Hedlund)

Prozac Timeline

May 25, 1984

Internal memorandum from Eli Lilly and Company [ pdf 01]

June 26, 1984

BGA (German equivalent of FDA) Report [ pdf 02]

January 29, 1985

BGA (German equivalent of FDA) Report [pdf 03]

February 26, 1985

BGA (German equivalent of FDA) Report [ pdf 04]

April 1, 1986

BGA (German equivalent of FDA) Memorandum [ pdf 05]

August 30, 1989

BGA Consultant Group Feedback [ pdf 06]

March 23, 1985

FDA Safety Review of Prozac [ pdf 07]

March 23, 1985

FDA Safety Review of Prozac [ pdf 08]

March 23, 1985

FDA Safety Review of Prozac [ pdf 09]

February, 1990

Harvard Study:

Emergence of Intense Suicidal Preoccupation During Fluoxetine [Prozac] Treatment [ pdf 10]

November 16, 1994

Testimony of Lilly Representative, Dr. Gary Tollefson [ pdf 11]

October 3, 1990

FDA Memorandum [ pdf 12]

September 20, 1991

FDA Psychopharmacological Drugs Advisory Committee [ pdf 13]

Our Awards

Biffle vs. Eli Lilly

Defendants Amend and Supplemental Answers to Plaintiffs’ First Interrogatories [ pdf 14]

June 3, 1992

Letter from FDA to Public Citizen [ pdf 15]

January 20, 1994

Pfizer Memorandum [ pdf 16] Obtained in Litigation

Written by Pfizer’s top scientist at the time

September 11, 1990

FDA Memorandum [ pdf 17]

Obtained through the Freedom of Information Act

Dr. David Graham

November 23, 2006

New England Journal of Medicine:

Dangerous Deception — Hiding the Evidence of Adverse Drug Effects [ pdf 18]

Jeffrey Avorn, MD

October 14, 2004

New England Journal of Medicine:

A Black Box Warning for Antidepressants in Children? [ pdf 20]

Thomas B. Newman, MD, MPH

September 23, 2004

Hearing: House of Representatives Committee on Energy and Commerce

Oversight and Investigations Subcommittee [ pdf 21]

108th Congress

February 2, 2004

FDA Psychopharmacological Drugs Advisory Committee [ pdf 22]

May, 2006

GSK Important Prescribing Information [ pdf 23]

July 15, 2002

American Psychological Association:

Antidepressants and Placebos: Secrets, Revelations and Unanswered Questions [ pdf 24]

Irving Kirsch, Alan Scoboria and Thomas J. Moore

July 15, 2005

British Medical Journal:

Efficacy of Antidepressants in Adults [ pdf 25]

Joanna Moncrieff and Irving Kirsch

December 24, 1991

FDA Memorandum [ pdf 26]

Firm Reviews

What Our Clients Are Saying
  • I Can’t Imagine a Better Law Firm

    “Multiple lawyers recommended Wisner Baum to me and I have been consistently impressed with the quality of their work.”

    - Best Law Firms Survey
  • They Are About Changing the Systems...

    “Wisner Baum are not only amazing attorneys but more importantly, they are activists. They are about changing the systems which got us into trouble in the first place. They understand their role in the process of making change.”

    - Kim Witczak
  • Top Legal Minds in the Country

    “The Wisner Baum firm has some of the top legal minds in the country; they are driven, determined, trustworthy, ethical and passionate.”

    - From Best Lawyers® Best Law Firms
  • Diligent & Professional Representation

    “Thanks to your efforts I was able to recover from a tragic experience and turn my life around for the best.”

    - W.T.
  • Our Best Interest Was Always Number One on Your List

    “A special thank you to your Spanish-speaking staff for the extra effort put into this case. The language barrier was never a problem, and we are so very thankful to them. Your name holds much respect in our family.”

    - G.C. & C.C

Contact Us Today

No Fees Unless We Win
  • Please enter your first name.
  • Please enter your last name.
  • +1
    Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please enter your city.
  • Please make a selection.
  • Please make a selection.
  • Please enter a message.